表紙
市場調查報告書

神經病變性疼痛治療藥的全球市場:2020年∼2024年

Global Neuropathy Pain Treatment Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 481449
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
神經病變性疼痛治療藥的全球市場:2020年∼2024年 Global Neuropathy Pain Treatment Market 2020-2024
出版日期: 2020年04月20日內容資訊: 英文 120 Pages
簡介

全球神經病變性疼痛治療藥市場在2020年∼2024年的預測期間內,預計將以5%的年複合成長率推移,並成長到17億289萬美元的規模。市場成長的主要因素有龐大的患者族群存在,以及專注於開發皰疹後神經痛的新療法。

本報告提供全球神經病變性疼痛治療市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

不同症狀市場區隔

  • 市場區隔
  • 不同症狀比較
  • 糖尿病神經病變-市場規模與預測2019-2024
  • 化療誘導神經病變性疼痛-市場規模與預測2019-2024
  • 帶狀皰疹後遺症神經痛-市場規模與預測2019-2024
  • 其他-市場規模與預測2019-2024
  • 不同症狀市場機會

各類藥物市場區隔

  • 鈣離子通道Alpha2-Delta配體
  • 血清素-去甲腎上腺素再回收抑制劑(SNRI)
  • TCA
  • 類鴉片物質止痛藥
  • 其他

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 -市場規模與預測2019-2024
  • 歐洲-市場規模與預測2019-2024
  • 亞太地區-2019-2024市場規模與預測
  • 南美-市場規模與預測2019-2024
  • 中東·非洲地區-市場規模與預測2019-2024
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Assertio Therapeutics Inc.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Dr Reddy's Laboratories
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR43322

Technavio has been monitoring the neuropathy pain treatment market and it is poised to grow by $ 1702.89 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our reports on neuropathy pain treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the presence of large patient pool and focus toward the development of novel therapeutics for postherpetic neuralgia.

The neuropathy pain treatment market analysis includes type segment and geographic landscape.

Technavio's ‘ neuropathy pain treatment market ’ is segmented as below:

By Type:

  • Diabetic neuropathy
  • Chemotherapy-induced neuropathy pain
  • Postherpetic neuralgia
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the growing focus on the development of drugs for the treatment of diabetic neuropathy pain as one of the prime reasons driving the neuropathy pain treatment market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our neuropathy pain treatment market covers the following areas:

  • Neuropathy pain treatment market sizing
  • Neuropathy pain treatment market forecast
  • Neuropathy pain treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuropathy pain treatment market vendors that include Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi. Also, the neuropathy pain treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Indication

  • Market segments
  • Comparison by Indication
  • Diabetic neuropathy - Market size and forecast 2019-2024
  • Chemotherapy-induced neuropathy pain - Market size and forecast 2019-2024
  • Postherpetic neuralgia - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by indication

Market Segmentation by drug class

  • Calcium channel alpha 2-delta ligands
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs)
  • TCAs
  • Opioid analgesics
  • Others

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Assertio Therapeutics Inc.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Dr Reddy's Laboratories
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Other1 - Market share 2019-2024 (%)
  • 22: Comparison by Other1
  • 23: Diabetic neuropathy - Market size and forecast 2019-2024 ($ million)
  • 24: Diabetic neuropathy - Year-over-year growth 2019-2024 (%)
  • 25: Chemotherapy-induced neuropathy pain - Market size and forecast 2019-2024 ($ million)
  • 26: Chemotherapy-induced neuropathy pain - Year-over-year growth 2019-2024 (%)
  • 27: Postherpetic neuralgia - Market size and forecast 2019-2024 ($ million)
  • 28: Postherpetic neuralgia - Year-over-year growth 2019-2024 (%)
  • 29: Others - Market size and forecast 2019-2024 ($ million)
  • 30: Others - Year-over-year growth 2019-2024 (%)
  • 31: Market opportunity by Other1
  • 32: Customer landscape
  • 33: Market share by geography 2019-2024 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2019-2024 ($ million)
  • 36: North America - Year-over-year growth 2019-2024 (%)
  • 37: Europe - Market size and forecast 2019-2024 ($ million)
  • 38: Europe - Year-over-year growth 2019-2024 (%)
  • 39: APAC - Market size and forecast 2019-2024 ($ million)
  • 40: APAC - Year-over-year growth 2019-2024 (%)
  • 41: South America - Market size and forecast 2019-2024 ($ million)
  • 42: South America - Year-over-year growth 2019-2024 (%)
  • 43: MEA - Market size and forecast 2019-2024 ($ million)
  • 44: MEA - Year-over-year growth 2019-2024 (%)
  • 45: Key leading countries
  • 46: Market opportunity by geography ($ million)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: Abbott Laboratories - Overview
  • 54: Abbott Laboratories - Business segments
  • 55: Abbott Laboratories - Key offerings
  • 56: Abbott Laboratories - Key customers
  • 57: Abbott Laboratories - Segment focus
  • 58: Assertio Therapeutics Inc. - Overview
  • 59: Assertio Therapeutics Inc. - Business segments
  • 60: Assertio Therapeutics Inc. - Key offerings
  • 61: Assertio Therapeutics Inc. - Key customers
  • 62: Assertio Therapeutics Inc. - Segment focus
  • 63: AstraZeneca Plc - Overview
  • 64: AstraZeneca Plc - Business segments
  • 65: AstraZeneca Plc - Key offerings
  • 66: AstraZeneca Plc - Key customers
  • 67: AstraZeneca Plc - Segment focus
  • 68: Baxter International Inc. - Overview
  • 69: Baxter International Inc. - Business segments
  • 70: Baxter International Inc. - Key offerings
  • 71: Baxter International Inc. - Key customers
  • 72: Baxter International Inc. - Segment focus
  • 73: Eli Lilly and Co. - Overview
  • 74: Eli Lilly and Co. - Business segments
  • 75: Eli Lilly and Co. - Key offerings
  • 76: Eli Lilly and Co. - Key customers
  • 77: Eli Lilly and Co. - Segment focus
  • 78: Endo International Plc - Overview
  • 79: Endo International Plc - Business segments
  • 80: Endo International Plc - Key offerings
  • 81: Endo International Plc - Key customers
  • 82: Endo International Plc - Segment focus
  • 83: Johnson & Johnson - Overview
  • 84: Johnson & Johnson - Business segments
  • 85: Johnson & Johnson - Key offerings
  • 86: Johnson & Johnson - Key customers
  • 87: Johnson & Johnson - Segment focus
  • 88: Pfizer Inc. - Overview
  • 89: Pfizer Inc. - Business segments
  • 90: Pfizer Inc. - Key offerings
  • 91: Pfizer Inc. - Key customers
  • 92: Pfizer Inc. - Segment focus
  • 93: Sanofi - Overview
  • 94: Sanofi - Business segments
  • 95: Sanofi - Key offerings
  • 96: Sanofi - Key customers
  • 97: Sanofi - Segment focus
  • 98: Currency conversion rates for US$
  • 99: Research Methodology
  • 100: Validation techniques employed for market sizing
  • 101: Information sources
  • 102: List of abbreviations